Treatment choices for patients with rheumatoid arthritis is expected to widen even more

Published: 2014-06-09 15:57:54

Updated: 2014-06-09 15:57:54

Rheumatoid arthritis treatment options are evolving, so patients have a much wider choice.

The conventional treatment of rheumatoid arthritis includes TNF-alpha inhibitor, Humira (adalimumab) of Abbvie. Another TNF-alpha inhibitors include Remicade (infliximab) of Janssen, and Enbrel (etanercept) of Pfizer. In addition, Simponi (golimumab) of Janssen and Remsima (infliximab) of Celltrion are s...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.